Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 29% ± 12% | |
astrocyte | 10 studies | 27% ± 11% | |
oligodendrocyte | 10 studies | 31% ± 9% | |
glutamatergic neuron | 9 studies | 41% ± 24% | |
microglial cell | 9 studies | 32% ± 10% | |
macrophage | 7 studies | 34% ± 10% | |
interneuron | 6 studies | 33% ± 17% | |
neuron | 6 studies | 40% ± 20% | |
oligodendrocyte precursor cell | 6 studies | 27% ± 11% | |
retinal cone cell | 6 studies | 22% ± 3% | |
GABAergic neuron | 6 studies | 44% ± 20% | |
retinal rod cell | 5 studies | 27% ± 8% | |
epithelial cell | 5 studies | 28% ± 4% | |
fibroblast | 5 studies | 19% ± 4% | |
retina horizontal cell | 5 studies | 22% ± 4% | |
amacrine cell | 4 studies | 23% ± 5% | |
retinal bipolar neuron | 4 studies | 19% ± 2% | |
endothelial cell of lymphatic vessel | 4 studies | 22% ± 3% | |
GABAergic interneuron | 3 studies | 26% ± 7% | |
granule cell | 3 studies | 24% ± 6% | |
myeloid cell | 3 studies | 30% ± 8% | |
lymphocyte | 3 studies | 20% ± 4% | |
monocyte | 3 studies | 21% ± 4% | |
T cell | 3 studies | 19% ± 4% | |
alveolar macrophage | 3 studies | 27% ± 7% | |
mast cell | 3 studies | 25% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2005.84 | 459 / 459 | 100% | 15.65 | 1117 / 1118 |
ovary | 100% | 4099.68 | 180 / 180 | 100% | 18.93 | 429 / 430 |
brain | 100% | 2767.86 | 2637 / 2642 | 100% | 12.52 | 702 / 705 |
uterus | 100% | 3042.48 | 170 / 170 | 99% | 17.98 | 454 / 459 |
esophagus | 100% | 2248.77 | 1445 / 1445 | 99% | 11.45 | 181 / 183 |
lung | 100% | 2258.08 | 578 / 578 | 99% | 15.44 | 1140 / 1155 |
skin | 100% | 1257.49 | 1803 / 1809 | 99% | 18.06 | 467 / 472 |
prostate | 100% | 2485.79 | 245 / 245 | 98% | 10.17 | 494 / 502 |
pancreas | 100% | 1826.14 | 328 / 328 | 98% | 10.47 | 175 / 178 |
bladder | 100% | 2139.14 | 21 / 21 | 98% | 12.81 | 492 / 504 |
thymus | 100% | 2745.24 | 653 / 653 | 97% | 10.15 | 588 / 605 |
intestine | 100% | 3029.76 | 966 / 966 | 97% | 9.23 | 511 / 527 |
stomach | 100% | 2251.95 | 359 / 359 | 95% | 10.00 | 272 / 286 |
adrenal gland | 100% | 3239.98 | 258 / 258 | 93% | 10.22 | 214 / 230 |
kidney | 100% | 1852.27 | 89 / 89 | 92% | 8.03 | 831 / 901 |
liver | 98% | 811.08 | 221 / 226 | 75% | 6.67 | 306 / 406 |
adipose | 100% | 1797.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2346.56 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3783.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.47 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.35 | 1 / 1 |
blood vessel | 100% | 1855.48 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1315.37 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 2111.53 | 897 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 14.40 | 77 / 80 |
lymph node | 0% | 0 | 0 / 0 | 83% | 8.13 | 24 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046500 | Biological process | S-adenosylmethionine metabolic process |
GO_0032355 | Biological process | response to estradiol |
GO_0007283 | Biological process | spermatogenesis |
GO_0032259 | Biological process | methylation |
GO_0010212 | Biological process | response to ionizing radiation |
GO_0071361 | Biological process | cellular response to ethanol |
GO_0141068 | Biological process | autosome genomic imprinting |
GO_1900039 | Biological process | positive regulation of cellular response to hypoxia |
GO_0006346 | Biological process | DNA methylation-dependent heterochromatin formation |
GO_1903926 | Biological process | cellular response to bisphenol A |
GO_0031048 | Biological process | regulatory ncRNA-mediated heterochromatin formation |
GO_0010288 | Biological process | response to lead ion |
GO_0044027 | Biological process | negative regulation of gene expression via chromosomal CpG island methylation |
GO_0033189 | Biological process | response to vitamin A |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0030182 | Biological process | neuron differentiation |
GO_0042220 | Biological process | response to cocaine |
GO_0097284 | Biological process | hepatocyte apoptotic process |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0009636 | Biological process | response to toxic substance |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0000775 | Cellular component | chromosome, centromeric region |
GO_1902494 | Cellular component | catalytic complex |
GO_0000792 | Cellular component | heterochromatin |
GO_0000791 | Cellular component | euchromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0001741 | Cellular component | XY body |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003886 | Molecular function | DNA (cytosine-5-)-methyltransferase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0106363 | Molecular function | protein-cysteine methyltransferase activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0106222 | Molecular function | lncRNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0045322 | Molecular function | unmethylated CpG binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DNMT3A |
Protein name | DNMT3A protein DNA methyltransferase 3 alpha DNA (cytosine-5-)-methyltransferase (EC 2.1.1.37) DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-) (DNA methyltransferase HsaIIIA) (DNA MTase HsaIIIA) (M.HsaIIIA) |
Synonyms | |
Description | FUNCTION: Required for genome-wide de novo methylation and is essential for the establishment of DNA methylation patterns during development . DNA methylation is coordinated with methylation of histones . It modifies DNA in a non-processive manner and also methylates non-CpG sites . May preferentially methylate DNA linker between 2 nucleosomal cores and is inhibited by histone H1 (By similarity). Plays a role in paternal and maternal imprinting (By similarity). Required for methylation of most imprinted loci in germ cells (By similarity). Acts as a transcriptional corepressor for ZBTB18 (By similarity). Recruited to trimethylated 'Lys-36' of histone H3 (H3K36me3) sites (By similarity). Can actively repress transcription through the recruitment of HDAC activity (By similarity). Also has weak auto-methylation activity on Cys-710 in absence of DNA (By similarity). . |
Accessions | A0A8I5KXG9 ENST00000264709.7 [Q9Y6K1-1] ENST00000470983.5 F8WE91 Q9Y6K1 A0A8I5KPS0 ENST00000402667.1 Q6PJ37 ENST00000380746.8 [Q9Y6K1-2] ENST00000482935.5 A0A8I5QKW3 ENST00000461228.1 ENST00000683393.1 ENST00000406659.3 [Q9Y6K1-3] ENST00000491288.5 ENST00000683760.1 ENST00000321117.10 [Q9Y6K1-1] ENST00000380756.7 A0A8I5KNQ0 A0A8I5KUD4 ENST00000474887.6 A0A0C4DG02 Q8WVA9 A0A8I5KTF6 |